Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

Despite new treatments for castrate-resistant prostate cancer (CRPC), the prognosis of patients with CRPC remains bleak due to acquired resistance to androgen receptor (AR)-directed therapy. The glucocorticoid receptor (GR) and AR share several transcriptional targets, including the anti-apoptotic g...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Horm Cancer
Hoofdauteurs: Isikbay, Masis, Otto, Kristen, Kregel, Steven, Kach, Jacob, Cai, Yi, Vander Griend, Donald J., Conzen, Suzanne D., Szmulewitz, Russell Z.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer US 2014
Onderwerpen:
Original Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4440041/
https://ncbi.nlm.nih.gov/pubmed/24615402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-014-0173-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items